The first-year class of students in the Milstein Program in Technology and Humanity are finishing up their community projects and looking forward to their summer in New York City.
The Yang-Tan WorkABILITY Incubator, recently launched through the ILR School’s Center for Applied Research on Work, will support innovative applied research projects and collaborations.
Targeting part of a key antiviral pathway may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
The Cornell Center for Health Equity has launched its racial allyship training course, providing anyone who wants to learn to be a better ally with essential skills and tools they can use in their personal and professional lives.
Pauline Flaum-Dunoyer has interviewed more than a dozen women physicians of color, and donated the recordings and transcripts to NewYork-Presbyterian/Weill Cornell Medicine, where their legacies will be preserved for future generations.
There will soon be a second “Feeney Way” at Cornell: a central thoroughfare at Cornell Tech to be named in honor of the transformative impact and legacy of Charles F. “Chuck” Feeney ’56, the university’s most generous donor.
The College of Human Ecology’s first Cornell Fashion Expo, held April 14, gave student designers a chance to present their work to industry experts and Cornell alumni in New York City, one of the fashion capitals of the world.
Strokes cause changes in gene activity in affected small blood vessels in the brain, changes that may be targetable with existing or future drugs to mitigate brain injury or improve stroke recovery, according to Weill Cornell Medicine scientists.
